Enlivex Therapeutics Stock Market Value
| ENLV Stock | USD 1.51 0.01 0.67% |
| Symbol | Enlivex |
Enlivex Therapeutics Price To Book Ratio
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enlivex Therapeutics. If investors know Enlivex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enlivex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Return On Assets (0.27) | Return On Equity (0.61) |
The market value of Enlivex Therapeutics is measured differently than its book value, which is the value of Enlivex that is recorded on the company's balance sheet. Investors also form their own opinion of Enlivex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enlivex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enlivex Therapeutics' market value can be influenced by many factors that don't directly affect Enlivex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enlivex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enlivex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enlivex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Enlivex Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enlivex Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enlivex Therapeutics.
| 10/03/2022 |
| 09/22/2024 |
If you would invest 0.00 in Enlivex Therapeutics on October 3, 2022 and sell it all today you would earn a total of 0.00 from holding Enlivex Therapeutics or generate 0.0% return on investment in Enlivex Therapeutics over 720 days. Enlivex Therapeutics is related to or competes with Hut 8, HIVE Blockchain, Bit Digital, Terawulf, Bitfarms, Marathon Digital, and Riot Blockchain. Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company More
Enlivex Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enlivex Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enlivex Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.39 | |||
| Information Ratio | 0.0472 | |||
| Maximum Drawdown | 24.6 | |||
| Value At Risk | (4.73) | |||
| Potential Upside | 5.11 |
Enlivex Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enlivex Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enlivex Therapeutics' standard deviation. In reality, there are many statistical measures that can use Enlivex Therapeutics historical prices to predict the future Enlivex Therapeutics' volatility.| Risk Adjusted Performance | 0.071 | |||
| Jensen Alpha | 0.216 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.0564 | |||
| Treynor Ratio | 0.3896 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enlivex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enlivex Therapeutics Backtested Returns
At this stage we consider Enlivex Stock to be relatively risky. Enlivex Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0453, which denotes the company had a 0.0453% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Enlivex Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Enlivex Therapeutics' Downside Deviation of 3.39, mean deviation of 2.69, and Coefficient Of Variation of 1284.44 to check if the risk estimate we provide is consistent with the expected return of 0.18%. Enlivex Therapeutics has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.78, which means possible diversification benefits within a given portfolio. As returns on the market increase, Enlivex Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Enlivex Therapeutics is expected to be smaller as well. Enlivex Therapeutics right now shows a risk of 4.07%. Please confirm Enlivex Therapeutics treynor ratio, as well as the relationship between the expected short fall and day median price , to decide if Enlivex Therapeutics will be following its price patterns.
Auto-correlation | 0.37 |
Below average predictability
Enlivex Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Enlivex Therapeutics time series from 3rd of October 2022 to 28th of September 2023 and 28th of September 2023 to 22nd of September 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enlivex Therapeutics price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Enlivex Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.82 |
Enlivex Therapeutics lagged returns against current returns
Autocorrelation, which is Enlivex Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enlivex Therapeutics' stock expected returns. We can calculate the autocorrelation of Enlivex Therapeutics returns to help us make a trade decision. For example, suppose you find that Enlivex Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Enlivex Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enlivex Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enlivex Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enlivex Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Enlivex Therapeutics Lagged Returns
When evaluating Enlivex Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enlivex Therapeutics stock have on its future price. Enlivex Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enlivex Therapeutics autocorrelation shows the relationship between Enlivex Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Enlivex Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Enlivex Stock Analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.